Coherus BioSciences Inc Capital Reinvestment Ratio
Coherus BioSciences Inc capital reinvestment ratio. Coherus BioSciences Inc (CHRS) has a Capital Reinvestment Ratio of 0.02x as of September 2021, meaning it reinvests 0% of its operating cash flow ($13.71 Million) in capital expenditures ($261.00K). Check CHRS cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Coherus BioSciences Inc (2013–2020)
Capital reinvestment ratio of Coherus BioSciences Inc from 2013 to 2020. This chart tracks Coherus BioSciences Inc's Capital Reinvestment Ratio across 3 annual periods. Also explore Coherus BioSciences Inc annual equity growth to track the company's year-over-year net asset growth rate.
Coherus BioSciences Inc Capital Reinvestment Ratio by Year (2013–2020)
Coherus BioSciences Inc capital reinvestment ratio by year from 2013 to 2020. For the full cash flow conversion analysis, see Coherus BioSciences Inc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.05x | $154.15 Million | $7.23 Million | ▼ -89.7% |
| 2019 | 0.45x | $28.36 Million | $12.90 Million | ▲ +1780.7% |
| 2013 | 0.02x | $15.42 Million | $373.00K | — |